Pharmacotherapy of respiratory syncytial virus infection (original) (raw)

Pharmacologic Advances in the Treatment and Prevention of Respiratory Syncytial Virus

Louis Saravolatz

Clinical Infectious Diseases, 2010

View PDFchevron_right

Pharmacokinetics, Safety, and Antiviral Effects of Multiple Doses of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678, in Infants Hospitalized With RSV Infection: A Randomized Phase 1b Study

Bart Remmerie

Clinical Infectious Diseases, 2020

View PDFchevron_right

Novel and Specific Respiratory Syncytial Virus Inhibitors That Target Virus Fusion

Boris Feld

Journal of Medicinal Chemistry, 1998

View PDFchevron_right

Respiratory syncytial virus: current and emerging treatment options

Grace Christopher Paul

ClinicoEconomics and Outcomes Research, 2014

View PDFchevron_right

Evaluation of Small Molecule Combinations against Respiratory Syncytial Virus In Vitro

Ralf Altmeyer

Molecules, 2021

View PDFchevron_right

Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB 209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV disease

Robert Welliver

Antimicrobial agents and chemotherapy, 1999

View PDFchevron_right

Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor

Michael Battles

Nature Communications

View PDFchevron_right

Effectiveness of drug therapies to treat or prevent respiratory syncytial virus infection-related morbidity

Simon Broughton

Expert Opinion on Pharmacotherapy, 2003

View PDFchevron_right

Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV)

Ruben Tommasi

Proceedings of the National Academy of Sciences, 2011

View PDFchevron_right

Oral Efficacy of a Respiratory Syncytial Virus Inhibitor in Rodent Models of Infection

Ivette Medina

Antimicrobial Agents and Chemotherapy, 2004

View PDFchevron_right

Orally Active Fusion Inhibitor of Respiratory Syncytial Virus

Nicholas Meanwell

Antimicrobial Agents and Chemotherapy, 2004

View PDFchevron_right

Therapeutic targeting of respiratory syncytial virus G-protein

Ralph Tripp

Immunotherapy, 2010

View PDFchevron_right

Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results

Kathia Luciani

PLOS ONE, 2023

View PDFchevron_right

Pharmacokinetics-Pharmacodynamics of a Respiratory Syncytial Virus Fusion Inhibitor in the Cotton Rat Model

David Nauwelaers, Dirk Roymans, Loeckie Zwart

Antimicrobial Agents and Chemotherapy, 2010

View PDFchevron_right

Prevention of serious respiratory syncytial virus-related illness. I: Disease pathogenesis and early attempts at prevention

Val Hemming

Advances in Therapy, 2011

View PDFchevron_right

Challenges and Opportunities in Developing Respiratory Syncytial Virus Therapeutics

J. Devincenzo

Journal of Infectious Diseases, 2015

View PDFchevron_right

Comparative Effects of Two Neutralizing Anti-Respiratory Syncytial Virus (RSV) Monoclonal Antibodies in the RSV Murine Model: Time versus Potency

Asunción Mejías

Antimicrobial Agents and Chemotherapy, 2005

View PDFchevron_right

Preventing severe respiratory syncytial virus disease: passive, active immunisation and new antivirals

Sonia Saxena

Archives of Disease in Childhood, 2014

View PDFchevron_right

GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process

Dorothy Theodore

Antimicrobial agents and chemotherapy, 2015

View PDFchevron_right

Management of Infections Caused by Respiratory Syncytial Virus

Jan Andersson, Lars Navér

Scandinavian Journal of Infectious Diseases, 2001

View PDFchevron_right

Differential antiviral activities of respiratory syncytial virus (RSV) inhibitors in human airway epithelium

Mieke Boon

The Journal of antimicrobial chemotherapy, 2018

View PDFchevron_right

RFI-641, a Potent Respiratory Syncytial Virus Inhibitor

Yuri Raifeld, Boris Feld

Antimicrobial Agents and Chemotherapy, 2002

View PDFchevron_right

Respiratory syncytial virus infection: therapy and prevention

Robert Welliver

Paediatric Respiratory Reviews, 2004

View PDFchevron_right